Independent audit will verify company's compliance
INDIANAPOLIS, July 10 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced its support of the Pharmaceutical Research and Manufacturers of America (PhRMA) revised Code on Interactions with Healthcare Professionals (Code). As a part of its support, Lilly will commit to act in accordance with, or exceed, the new Code in its interactions with healthcare professionals. Moreover, Lilly will implement periodic external verification to ensure that the company has policies and procedures in place to foster compliance with the Code.
Lilly's support coincides with today's announcement by PhRMA, whose Board of Directors approved the revised Code at its June 2008 meeting. Lilly is a member of PhRMA and played an active role in driving the Code revisions.
"Our sales representatives are a valuable resource to healthcare professionals, informing them about the scientific advancements in medicine," said Robert Brown, chief marketing and operations officer for Lilly's U.S. operations. "We believe that the meaningful Code revisions that have been adopted will address the concerns of our various stakeholders and strengthen the public trust in our industry."
"Lilly believes the revised Code will help to ensure that the information exchange with healthcare providers continues to be appropriate and ethical," said Brown.
The new Code will set a new standard for appropriate sales and marketing practices, while codifying many of the practices already common within the industry. Some of the changes include, but are not limited to, the following:
-- Limits meals to modest, occasional, in-office with informational
presentations. Allows outside
|SOURCE Eli Lilly and Company|
Copyright©2008 PR Newswire.
All rights reserved